Rapid Therapeutic Science Laboratories, Inc. (RTSL) Times Interest Earned (2018 - 2023)
Rapid Therapeutic Science Laboratories' Times Interest Earned history spans 6 years, with the latest figure at -$1.71 for Q2 2023.
- For Q2 2023, Times Interest Earned fell 916.96% year-over-year to -$1.71; the TTM value through Jun 2023 reached -$0.93, down 26.97%, while the annual FY2022 figure was -$0.67, 59.45% up from the prior year.
- Times Interest Earned for Q2 2023 was -$1.71 at Rapid Therapeutic Science Laboratories, down from -$0.89 in the prior quarter.
- Across five years, Times Interest Earned topped out at $0.39 in Q4 2022 and bottomed at -$160.95 in Q2 2021.
- The 5-year median for Times Interest Earned is -$1.11 (2022), against an average of -$17.86.
- The largest annual shift saw Times Interest Earned crashed 4727.8% in 2020 before it surged 140.07% in 2022.
- A 5-year view of Times Interest Earned shows it stood at -$4.07 in 2019, then plummeted by 647.01% to -$30.43 in 2020, then soared by 96.82% to -$0.97 in 2021, then soared by 140.07% to $0.39 in 2022, then crashed by 540.16% to -$1.71 in 2023.
- Per Business Quant, the three most recent readings for RTSL's Times Interest Earned are -$1.71 (Q2 2023), -$0.89 (Q1 2023), and $0.39 (Q4 2022).